Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
76 studies found for:    "congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency" OR "Congenital Adrenal Hyperplasia" OR "Adrenal Hyperplasia, Congenital"
Show Display Options
Download search resultsDownload the search results for:
"congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency" OR "Congenital Adrenal Hyperplasia" OR "Adrenal Hyperplasia, Congenital" (76 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Active, not recruiting Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Interventions: Drug: Hydrocortisone;   Drug: Cortisone acetate
2 Completed Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention: Drug: Hydrocortisone sodium acetate
3 Recruiting A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: ATR-101
4 Completed Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention:
5 Completed Study of UK Adults With Congenital Adrenal Hyperplasia.
Condition: Congenital Adrenal Hyperplasia
Intervention:
6 Completed Examining Genetic Differences Among People With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Procedure: Hydrocortisone withdrawal
7 Completed
Has Results
Dexamethasone Treatment of Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Interventions: Drug: dexamethasone;   Drug: Hydrocortisone
8 Completed Qualitative Research on Women With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Other: Interview
9 Withdrawn Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: NBI-77860
10 Unknown  Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia
Condition: Adrenal Hyperplasia, Congenital
Intervention:
11 Recruiting COrticosteroid in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Interventions: Biological: Hormonal balance measurements;   Biological: metabolic balance measurements;   Biological: bone balance measurements;   Behavioral: quality of life assessment
12 Unknown  Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers
Condition: Adrenal Hyperplasia, Congenital
Intervention:
13 Completed Effects of Pioglitazone in Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Pioglitazone
14 Recruiting Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
Condition: Congenital Adrenal Hyperplasia
Interventions: Drug: Chronocort®;   Drug: standard glucocorticoid therapy
15 Not yet recruiting Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
Condition: Congenital Adrenal Hyperplasia
Intervention: Drug: Abiraterone acetate
16 Completed A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency
Condition: 21-hydroxylase Deficiency
Intervention: Drug: Abiraterone acetate
17 Active, not recruiting Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency.
Conditions: Adrenal Hyperplasia, Congenital;   21-hydroxylase Deficiency
Intervention: Other: Functional explorations
18 Completed Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   Healthy
Intervention:
19 Active, not recruiting Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia;   Growth Disorder
Interventions: Drug: Flutamide and Testolactone;   Drug: Deslorelin
20 Active, not recruiting Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia
Conditions: Addison Disease;   Adrenal Hyperplasia Congenital
Interventions: Drug: Solu-Cortef;   Drug: Cortef

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.